Hormone Therapy for Cancer is a Risk Factor for Relapse of Inflammatory Bowel Diseases

BACKGROUND & AIMS: Exposure to hormone contraception has been associated with an increased risk of relapse of inflammatory bowel diseases (IBD). Little is known about the effects of cancer therapies, specifically hormone therapies, on the course of IBD. METHODS: We conducted a retrospective coho...

Descripción completa

Detalles Bibliográficos
Autores principales: Axelrad, Jordan E., Bazarbashi, Ahmad, Zhou, James, Castañeda, Daniel, Gujral, Amandeep, Sperling, Dylan, Glass, Jason, Agrawal, Manasi, Hong, Simon, Lawlor, Garrett, Hudesman, David, Chang, Shannon, Shah, Shailja, Yajnik, Vijay, Ananthakrishnan, Ashwin, Khalili, Hamed, Colombel, Jean-Frederic, Itzkowitz, Steven
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2019
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354097/
https://www.ncbi.nlm.nih.gov/pubmed/31302306
http://dx.doi.org/10.1016/j.cgh.2019.06.042

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7354097/
https://www.ncbi.nlm.nih.gov/pubmed/31302306
http://dx.doi.org/10.1016/j.cgh.2019.06.042

Ejemplares similares